Shanghai Shyndec Pharmaceutical Co., Ltd.

Share · CNE000001JG2 (XSHG)

Overview

No Price

Closing Price XSHG 28.01.2026: 10,62 CNY

28.01.2026 06:44

Current Prices from Shanghai Shyndec Pharmaceutical Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SSE	600420.SS	CNY	28.01.2026 06:44	10,62 CNY	0,02 CNY +0,19 %

Share Float & Liquidity

Free Float 51,88 %

Shares Float 695,76 M

Shares Outstanding 1,34 B

Company Profile for Shanghai Shyndec Pharmaceutical Co., Ltd. Share

Shanghai Shyndec Pharmaceutical Co., Ltd. manufactures drug preparation products in China and internationally. It focuses on anti-infection, cardiovascular and cerebrovascular, anti-tumor, metabolism, and endocrine areas. The company was founded in 1996 and is based in Shanghai, China.

AI Analysis of Shanghai Shyndec Pharmaceutical Co., Ltd.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Shanghai Shyndec Pharmaceutical Co., Ltd.

No AI threads available for this company yet.

Company Data

Name Shanghai Shyndec Pharmaceutical Co., Ltd.

Company Shanghai Shyndec Pharmaceutical Co., Ltd.

Website https://www.shyndec.com

Primary Exchange

SSE

ISIN CNE000001JG2

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Yong Liu

Market Capitalization 14 Mrd.

Country China

Currency CNY

Employees 11,5 T

Address Building 1, 200040 Shanghai

IPO Date 2004-06-16

Dividends from 'Shanghai Shyndec Pharmaceutical Co., Ltd.'

Ex-Date	Dividend per Share
16.09.2025	0,10 CNY

Ticker Symbols

Name	Symbol
SSE	600420.SS

More Shares

Investors who hold Shanghai Shyndec Pharmaceutical Co., Ltd. also have the following shares in their portfolio:

INDUSTRL BK O.KOR.GDRS/1 Share

UNITED UTILITIES WATER FINANCE PLC 1.641% NTS 09/06/31 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog